A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study

Clin Lung Cancer. 2024 Mar 15:S1525-7304(24)00038-X. doi: 10.1016/j.cllc.2024.03.003. Online ahead of print.NO ABSTRACTPMID:38584069 | DOI:10.1016/j.cllc.2024.03.003

Source: Clinical Lung Cancer - April 7, 2024 Category: Cancer & Oncology Authors: Edward B Garon Byoung Chul Cho Alexander Luft Jorge Alatorre-Alexander Sarayut Lucien Geater Dmytro Trukhin Sang-We Kim Grygorii Ursol Maen Hussein Farah Louise Lim Cheng-Ta Yang Luiz Henrique Araujo Haruhiro Saito Niels Reinmuth Milena Kohlmann Caitlin L Source Type: research